Disorders of bone health Flashcards
(29 cards)
osteoclasts
bone breakdown/ resorption cells
osteoblasts
bone forming cells
osteocytes
mature bone cells within bone matrix
help to maintain bone and act as mechanosensors
what happens to bone with increasing age
increased osteoclast activity whihc is not matched by increased osteoblast activity
imbalance of bone breakdown and formation leading to osteoporosis
osteoporosis
progressive systemic skeletal disease characterised by low bone mass and micro architectural deterioration of bone tissue with consequent increase in bone fragility and susceptibilty to fracture
what happens to bone as you age
decreases in trabecular thickness
decrease in number of connections between vertical trabeculae
decrease in trabecular strength
percentages of clinical outcomes
50% hip fracture patients cannot live independantly
20% of hip fracture patients die within a year of their fracture
most widely used method of measurig bmd
DXA scans- predicts fracture risk independantly of other risk factors
t score BMD reference ranges
Normal: -1.0 and above
Osteopenia (low bone mass): Between -1.0 and -2.5
Osteoporosis: -2.5 or lower
Severe Osteoporosis: -2.5 or lower with a history of fragility fractures
lifestyle advice for management of osteoporosis
high intensity strength training
low impact weight bearing excersize
avoidance of excess alcohol
avoidance of smoking
fall prevention
drug treatments for osteoporosis
calcium and vit d supplementation
bisphosphonates
denosumab
teriparatide
testosterone
HRT
MOA of bisphosphonates
inhibit bone resorption by osteoclasts
structure of bisphosphonates
analogs of phosphate, a natural compound involved in bone metabolism
what do bisphosphonates have a strong affinity for
hydroxyapatite in bone, allowing them to localize to areas of active bone resorption.
what happens when osteoclasts attempt to absorb bone containing bisphosphonates
the drugs are internalized by the osteoclasts.
* Inside osteoclasts, bisphosphonates interfere with essential cellular processes, impairing their ability to resorb bone
examples of bisphosphonates
alendronate and risedronate
denosumab
monoclonal antibody used primarily in the treatment of conditions involving bone loss
normal bone remodelling
in a programmed sequence at discrete foci called bone remodelling units
at the beginnning osteo clasts appear on a previously inactive surface and begin to resorb the bone
osteoclasts are replaced by osteoblasts that fill the cavity by putting down osteoid that is mineralised to form new bone
after normal bone remodelling the resorption is completely refilled wiht new bone unlike in osteoporosis
teriparatide
stimulates bone growth rather than reducing bone loss
anabolic agent
consider if severe osteoporosis
sclerostin
protein produced. by osteocytes that inhibits bone formation to prevent over stimulation in skeletal
romosozumab
humanised monocloncal antibody that inhibits sclerostin
improves BMD at hip and spine
when to treat osteoporosis
consider treatment with anti resorptive therapy when T score </=2.5
direct effects of corticosteroids on bone
reduction of osteoblast activity and lifespan
suppression of replication of osteoblast precursors
reduction in calcium absorption
indirect effects of corticosteroids on bone
inhibition of gonadal and adrenal steroid production